FSA guidance on cannabidiol products

cannabidiol (CBD) products

Today, the Food Standards Agency (FSA) updated their guidance on cannabidiol (CBD) products which can be purchased without prescription. With one in ten British adults reporting that they consume CBD products available without prescription, such as oils, gummies or beverages, it is important to consider what these recommendations mean for the general public. Consumer interest […]

Read More… from FSA guidance on cannabidiol products

Antibiotic potential for cannabis molecule

antibiotic potential

Research establishes antibiotic potential for cannabis molecule: Synthetic cannabidiol, better known as CBD, has been shown for the first time to kill the bacteria responsible for gonorrhoea, meningitis and legionnaires disease. The research collaboration between The University of Queensland and Botanix Pharmaceuticals Limited could lead to the first new class of antibiotics for resistant bacteria in 60 years. The […]

Read More… from Antibiotic potential for cannabis molecule

Cannabidiol could treat psychosis

cannabis for severe epilepsy

A constituent of cannabis known as cannabidiol could hold promise as a new class of treatment for psychosis, according to King’s College London research showing significant benefits in a clinical trial. The main psychoactive compound in cannabis is delta-9-tetrahydrocannabinol (THC), which is responsible for many of the drug’s harmful effects, such as paranoia and anxiety. […]

Read More… from Cannabidiol could treat psychosis

The highs and lows of cannabinoid

CBD

‘When people think of cannabis, they usually think of the recreational drug and the psychoactive compound THC. However, another very important component of cannabis, also known as hemp, is cannabidiol (CBD) which has no ‘high’ or side effects associated with cannabis. Indeed, it has many proven health benefits. Studies show that CBD has an impact […]

Read More… from The highs and lows of cannabinoid